Audio

Community Oncology Podcast - Everolimus for tuberous sclerosis

Publish date: December 30, 2012

 

Everolimus for tuberous sclerosis-associated tumors, BRCA testing in underserved women, and thoughts on cancer care site of service are the topics for the December 2012 Community Oncology podcast by Editor in Chief Dr. David Henry.

Recommended Reading

Medicare Okays Wound Plasma Gel for Clinical Trial Patients
MDedge Hematology and Oncology
SPECT/CT Before SLN Excision Improves Melanoma Survival
MDedge Hematology and Oncology
Dual Kinase Therapy Slows BRAF-Mutated Metastatic Melanoma
MDedge Hematology and Oncology
Health Care Professionals Tank in Cancer Survey
MDedge Hematology and Oncology
More Evidence Links Tanning Beds to Skin Cancer
MDedge Hematology and Oncology
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
MDedge Hematology and Oncology
Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Hematology and Oncology
Tuberous Sclerosis Skin Lesions Improved on Everolimus
MDedge Hematology and Oncology
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
MDedge Hematology and Oncology
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
MDedge Hematology and Oncology